Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 12Unknown 5Recruiting 4Withdrawn 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Hyperglycemia 1Colonic Neoplasms 1Breast Neoplasms 1

Interventions

Cisplatin 9pembrolizumab 7Radiosurgery 6Gemcitabine 6Paclitaxel 5Dexamethasone 5Taxes 4Carboplatin 4trametinib 3ibrutinib 3Surveys and Questionnaires 3Standard of Care 3Radiotherapy 3Nivolumab 3Magnetic Resonance Spectroscopy 3Lenalidomide 3Fluorouracil 3Erlotinib Hydrochloride 3Blood Specimen Collection 3Ascorbic Acid 3venetoclax 2veliparib 2tocilizumab 2pazopanib 2obinutuzumab 2naquotinib 2lenvatinib 2fludarabine 2enzalutamide 2Vemurafenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Neoplasms × Control Groups × Clear all
NCT02372539 2021-04-26

Glucose Variability in Cancer Patients Receiving Dexamethasone

University of Colorado, Denver

Withdrawn

Hyperglycemia, Neoplasms

NCT03253029 2017-08-24

Study of Branched-chain Amino Acids in Cancer Cachexia

Western Regional Medical Center

Phase NA Withdrawn
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡